Table of contents

Extended reports

• Enhanced gene transfer to arthritic joints using adeno-associated virus type 5: implications for intra-articular gene therapy (5 May, 2005) Free

  J Adriaansen, S W Tas, P L Klarenbeek, A C Bakker, F Apparailly, G S Firestein, C Jorgensen, M J B M Vervoordeldonk, P P Tak
• Inhibition of collagen gene expression in systemic sclerosis dermal fibroblasts by mithramycin (18 May, 2005) Free

  N Sandorfi, N Louneva, E Hitraya, G Hajnoczky, B Saitta, S A Jimenez
• Type I interferon correlates with serological and clinical manifestations of SLE (20 April, 2005) Free

  M C Dall’Era, P M Cardarelli, B T Preston, A Witte, J C Davis
• Anti-serum amyloid component P antibodies in patients with systemic lupus erythematosus correlate with disease activity (13 July, 2005) Free

  G Zandman-Goddard, M Blank, P Langevitz, L Slutsky, M Pras, Y Levy, O Shovman, T Witte, A Doria, J Rovensky, Y Shoenfeld
• EULAR report on the use of ultrasonography in painful knee osteoarthritis. Part 1: Prevalence of inflammation in osteoarthritis (5 May, 2005) Free

  M A D’Agostino, P Conaghan, M Le Bars, G Baron, W Grassi, E Martin-Mola, R Wakefield, J-L Brasseur, A So, M Backhaus, M Malaise, G Burmester, N Schmidely, P Ravaud, M Dougados, P Emery
• EULAR report on the use of ultrasonography in painful knee osteoarthritis. Part 2: Exploring decision rules for clinical utility (5 May, 2005) Free

  P Conaghan, M A D’Agostino, P Ravaud, G Baron, M Le Bars, W Grassi, E Martin-Mola, R Wakefield, J-L Brasseur, A So, M Backhaus, M Malaise, G Burmester, N Schmidely, P Emery, M Dougados
• Sports activities 5 years after total knee or hip arthroplasty: the Ulm Osteoarthritis Study (20 April, 2005) Free

  K Huch, K A C Müller, T Stürmer, H Brenner, W Puhl, K-P Günther
• Patellofemoral osteoarthritis coexistent with tibiofemoral osteoarthritis in a meniscectomy population (20 April, 2005) Free

  M Englund, L S Lohmander
• Three year joint space narrowing predicts long term incidence of knee surgery in patients with osteoarthritis: an eight year prospective follow up study (20 April, 2005) Free

  O Bruyere, F Richy, J-Y Reginster
• Autoantibody profiling as early diagnostic and prognostic tool for rheumatoid arthritis (5 May, 2005) Free

  V P K Nell, K P Machold, T A Stamm, G Eberl, H Heinzl, M Uffmann, J S Smolen, G Steiner
• Dendritic cells from patients with rheumatoid arthritis lack the interleukin 13 mediated increase of FcγRII expression, which has clear functional consequences (5 May, 2005) Free

  T R D J Radstake, K C A M Nabbe, M H Wenink, M F Roelofs, A Oosterlaar, A W T van Lieshout, P Barrera, P L E M van Lent, W B van den Berg
• Longitudinal analysis of citrullinated protein/peptide antibodies (anti-CP) during 5 year follow up in early rheumatoid arthritis: anti-CP status predicts worse disease activity and greater radiological progression (20 April, 2005) Free

  J Rönnelid, M C Wick, J Lampa, S Lindblad, B Nordmark, L Klareskog, R F van Vollenhoven
• Changes of cartilage and bone markers after intra-articular glucocorticoid treatment with and without postinjection rest in patients with rheumatoid arthritis (20 April, 2005) Free

  T Weitoft, A Larsson, T Saxne, L Rönnblom
• Productivity costs among patients with rheumatoid arthritis: the influence of methods and sources to value loss of productivity (28 April, 2005) Free

  S M M Verstappen, A Boonen, H Verkleij, J W J Bijlsma, E Buskens, J W G Jacobs
• Double blind, randomised, placebo controlled study of leflunomide in the treatment of active ankylosing spondylitis (18 May, 2005) Free

  J C van Denderen, M van der Paardt, M T Nurmohamed, Y M M A de Ryck, B A C Dijkmans, I E van der Horst-Bruinsma
• Do steroids increase lymphoma risk? A case–control study of lymphoma risk in polymyalgia rheumatica/giant cell arteritis (20 April, 2005) Free

  J Askling, L Klareskog, H Hjalgrim, E Baecklund, M Björkholm, A Ekbom
• Intracellular and extracellular CPPD crystals are a regular feature in synovial fluid from uninflamed joints of patients with CPPD related arthropathy (7 June, 2005) Free

  A Martínez Sanchis, E Pascual
• Variations in performance characteristics of commercial enzyme immunoassay kits for detection of antineutrophil cytoplasmic antibodies: what is the optimal cut off? (20 April, 2005) Free

  J U Holle, B Hellmich, M Backes, W L Gross, E Csernok